Skip to content


You currently have no items in your basket.

Total (excl. vat) £0.000
View basket & checkout

Clinical and Diagnostic Products

Presenting a new range of CE marked products from 2BScientific

Clinical and Diagnostic Products at 2BScientific

2BScientific present its new range of clinical diagnostic reagents, that are registered with UKCA for selling CE-marked/IVD products.

This means that the 2BScientific you visit for our 100% product satisfaction guarantee, express customer communication, and innovative reagents, now includes products that can be used for clinical diagnostic purposes.

Whether you are a healthcare professional, a team of researchers, or an individual seeking reliable and accurate disease diagnostic solutions, our teams can assist you to ensure you get the results you need.

Clinical and Diagnostic Products at 2BScientific

Clinical and Diagnostic reagents are widely used in the scientific community as valuable tools to obtain alternative approaches to data analysis. They are mainly used by:

  • Academic researchers to investigate novel disease pathways and build knowledge on new disease developments.

  • Researchers in the healthcare sectors use them to identify diseases, develop diagnostic methods, and advance drug discovery

  • Contract research organisations (CROs) utilise these reagents to offer research and development services to pharmaceutical and biotech companies

  •  Diagnostic testing companies depend on them for accurate and reliable testing results

  • Government research institutes and veterinary laboratories also seek these reagents for their respective research and diagnostic needs.

By providing high-quality clinical diagnostic reagents, 2BScientific supports the critical work of various lab-based researchers in the healthcare, government, and commercial sector to foster a culture of collaboration and innovation that supports scientific discovery and advancement.

Some of the key benefits our products offer to the researcher community are:

  • Ability to develop novel methods to identify unknown disease targets

  • Identify alternative methods to improve clinical data analysis

  • Generate potential biomarker analysis for disease stratification

  • Provides better funding support

  • Provides results optimisation and reproducibility in a timely manner

  • Ability to produce multiple tests at the same time with a single amount of human sample

  • Improve cost efficiency and reduce reagent wastage

Advantages of our Clinical and Diagnostic Product Range

  • Accurate and Early Diagnosis - By utilising these diagnostic products for quick and efficient development of results, it will enable healthcare professionals to make accurate and early diagnoses. This allows for prompt and targeted treatment, improving patient outcomes and potentially saving lives.

  • Disease Screening and Prevention - Our range of diagnostic products can offer disease screening methods. Post analysis they can enable healthcare providers to identify individuals at risk or in the early stages of certain disease conditions, facilitating timely intervention and preventive measures.

  • Personalised Medicine - These products offer the ability to improve personalised medicine by using human samples in multiple screening mechanisms, thereby tailoring treatment plans to an individual's specific genetic makeup or disease characteristics. This approach maximises treatment effectiveness, minimises adverse reactions, and optimises patient care.

  • Treatment Monitoring - The optimisation of these product by manufacturers, improve reporducibility of results, thereby playing a crucial role in monitoring the progress and effectiveness of treatments. They provide objective data that allows healthcare providers to adjust therapies as needed, ensuring optimal outcomes for patients.

  • Research and Development - These clinical diagnostic products are instrumental in advancing medical research and development. They facilitate the collection of data, biomaterials, and patient samples, enabling scientists to gain insights into disease mechanisms, evaluate new therapeutic approaches, and develop innovative medical technologies. This research ultimately leads to discovery of new treatments and improvements in patient care.

Learn more about our trusted IVD suppliers below:


A biotechnology company with 28 years of manufacturing experience in IVD technology, provide a large variety of clinical IVD assays for detection of bacterial, viral and other microbial infections in human samples. VIDIA offers ELISA kits, Immunoflorescence assays, RAPID Test kits, and LIA kits to determine diagnosis of a plethora of infectious serelogy for parasites, bacteria, viruses and fungal agents. VIDIA’s products offer accurate and rapid results for Gastro-intestinal infections and Respiratory infections that includes bacterial and virus agent detections.


Key benefits from these applications

  • Specificity of the biomarker can rapidly validate patient stractification for disease severity or progression for autoimmune diseases, cancer detection and identify types of infectious disease

  • Better treatment decisions with faster follow-up analysis

  • Faster detection of a variety of microbial infections and serology analysis


GenomeMe Lab Inc. is a Vancouver-based biotech company specialising in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since their inception in 2017, their goal has been to develop each of the 260+ clinical IHC antibodies in-house, making them the first and only institution to date to achieve this. GenomeMe Lab Inc. is rising to be a dominant player in diagnostic IHC applications, an increasingly essential part of future precision medicine technologies.

GenomeMe Best Sellers
p16 INK4a Clone: IHC116, Clone: IHC216
BAP1 Clone: IHC761
PAX-8 Clone: IHC008, Clone: IHC048

Optibodies by Nordic Biosite

Optibodies™ are a series of monoclonal antibodies for immunohistochemistry manufactured by Nordic BioSite. They were created to boost quality and create options for users of IHC biomarkers in clinical pathology. High quality is the driving force; only antibodies that reach excellent results in testing protocol and appropriate control tissues are approved as part of the collection. An important aspect is being user-friendly. Optibodies™ works for different protocols and platforms with standard buffers. Optibodies™ get high scores in NordiQC assessments, which is a confirmation of the high quality.

Optibodies by Nordic Biosite
OptibodiesTM Best Sellers
SOX-10 (list)
Napsin A (list)

Zeta Corporation

Zeta Corporation is a biomedical company based in Southern California with ISO 13485 and FDA certifications. Zeta develops, manufactures, and distributes highly specific and sensitive IVD antibodies for Pathology/IHC on FFPE tissue sections. Specifically, Zeta designs and develops tumour-specific biomarkers using cutting-edge technologies to uniquely select the immunogens for their famed MonoSpecific monoclonal antibodies. Zeta is committed to providing the highest quality of antibodies to aid pathologists in diagnosing human diseases.

Zeta Corporation
Zeta Corporation Best Sellers
PRAME (Z2674R)
LEF-1 (Z2642R)
CD123 Clone: ZR425 (Z2781R), Clone: ZM80 (Z2390M)